Sabinsa Corp. has filed lawsuits in the United States District Court, District of New Jersey, against four dietary supplement ingredient companies for making, selling, and/or importing products that infringe upon Sabinsa’s Tetrahydrocurcuminoid Patent covering compositions and methods of using Tetrahydrocurcuminoids in the US. The companies are: Olive Lifesciences Pvt. Ltd. (Bangalore, India), Nachurel Ingredients LLC(North Brunswick, NJ), Chemill Inc. (Bothell, WA), and Aegle Bios Inc. (Edison, NJ). Both Olive and Nachurel were named in a previous suit for infringement on another of Sabinsa’s patents.
The issued U.S. Patent No. 6,653,327, on the compositions and uses of turmeric-derived tetrahydrocurcuminoids is public knowledge, as is Sabinsa’s stated intent to protect the company’s intellectual property.
“We are determined to protect our intellectual property when our patents are infringed upon. These defendants’ customers are also infringing upon Sabinsa’s patents, most likely without their knowledge, so these infringing companies are putting their customer’s businesses at risk,” said Sabinsa founder Muhammed Majeed Ph.D. “We have been very outspoken in calling on industry manufacturers to respect intellectual property; to do otherwise both stifles innovation and does a disservice to those manufacturers who legitimately license intellectual property.”
“Sabinsa’s patent claims compositions and methods of using its tetrahydrocurcuminoid compositions” stated James H. Hulme, Esquire of Arent Fox LLP in Washington, DC, who represents Sabinsa in this matter. “Sabinsa will enforce its patent rights and protect its intellectual property to the fullest extent allowed by law,” he explained.
Sabinsa’s patent covers compositional claims and also several topical and oral applications of Tetrahydrocurcuminoids noted for their high anti-oxidant capacity.